Skip to main content
  • WHEN NANO COMES TO LIFE
  • WHEN NANO COMES TO LIFE
  • WHEN NANO COMES TO LIFE

WE RETHINK THERAPY

With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.

OUR VISION

We save human lives

by targeted use of highly potent substances

We rethink therapy

via tailor-made nanocarriers for efficiency and safety

We treat the untreatable

e.g. septic liver failure

NEWS

1st December 2025

NEW RESEARCH PROJECT STARTED

Together with Jena University Hospital (UKJ), we are developing a novel nanotherapy for steatohepatitis, an inflammatory form of fatty liver disease, as part of the RESOLVE joint project. Targeted nanocarriers will be used to deliver drugs directly to liver and immune cells in order to slow down inflammation, metabolic disorders, and fibrosis at an early stage. ...

24th November 2025

SMALL EXPERIMENTS – BIG FUN

On Friday evening, 21 November 2025, the popular science evening took place once again at the Talschule in Jena. The event is held every two years at this primary school since 2013 and inspires children, parents and teachers alike – with fascinating insights into the world of science. Four dedicated employees demonstrated their commitment at one of 30 stations: with mega particles, colourful reactions and many ‘aha’ moments...

19th November 2025

15 YEARS OF JCSM: SMARTDYELIVERY AT ANNIVERSARY CELEBRATION

On 17 November 2025, Friedrich Schiller University Jena celebrated the 15th anniversary of the Jena Centre for Soft Matter (JCSM) with a festive event at the Centre for Applied Research. Dr. Bernd Uwe Althaus, State Secretary in the Thuringian Ministry of Education, Science and Culture, praised the important role played by the JCSM in science, innovation and technology transfer in Thuringia. University President Prof. Dr. Andreas Marx highlighted the central importance of the center for the university's excellence strategy, while Prof. Dr. Stefan Leible, President of the University of Bayreuth, emphasized the importance of interdisciplinary cooperation. ...

105

Patents Granted

EP, US, JP, CN, CA …

108

Pending Applications

EP, US, JP, CN, CA …

1

Utility Model

Countless Company Secrets